The Trimbos Institute has been coordinating the Drug Information and Monitoring System (DIMS) for 30 years. Thanks to a nationwide network of test sites at addiction care facilities and others, the DIMS has a good picture of the Dutch drug market. The associated laboratory analyses will be performed from January 2023 by Brightlabs in Venlo. The Trimbos Institute and Brightlabs are pleased with this cooperation to further strengthen and continue to guarantee accurate drug sample testing.
Brightlabs is an analytical laboratory located in the Villaflora in Venlo. At Brightlabs, the focus is on pharmaceutical, cannabis, and research-driven analytical projects. The past period has been marked by cross-validation to ensure continued quality. Bart Jansen (Business
Development Manager Brightlabs) says he is proud of the collaboration with the Trimbos. "Being allowed to perform the drug analyses for the DIMS, in cooperation with the Trimbos, fits well with our activities. We are proud to contribute to a safer Netherlands."
Through a nationwide network of thirteen participants with 32 test sites in the Netherlands, the DIMS collects information about the drug market. With the goal of understanding recreational drugs in the Dutch market for prevention and as a warning system when an alarming substance is found on the drug market.
"The DIMS has a great impact because it has been in direct contact with thousands of users for years. Only that way, you get insight into what is really going on in the drug market. With that information, policies can be made locally, nationally, and internationally. I am happy with the cooperation with Brightlabs to further support us in this," says Laura Smit-Rigter, National coordinator DIMS.
For more information: